CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic

William A. Parsonage; Louise Cullen; David Brieger; Graham S. Hillis; Arthur Nasis; Nathan Dwyer; Sudhir Wahi; Sidney Lo; Martin Than; Andrew Kerr; Gerard Devlin; Derek K. Chew

doi:10.1016/j.hlc.2020.05.003

CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic

William A. Parsonage, Louise Cullen, David Brieger, Graham S. Hillis, Arthur Nasis, Nathan Dwyer, Sudhir Wahi, Sidney Lo, Martin Than, Andrew Kerr, Gerard Devlin, Derek K. Chew

Research output: Contribution to journal › Letter › peer-review

8 Citations (Scopus)

Abstract

A pandemic of Coronavirus-19 disease was declared by the World Health Organization on March 11, 2020. The pandemic is expected to place unprecedented demand on health service delivery. This position statement has been developed by the Cardiac Society of Australia and New Zealand to assist clinicians to continue to deliver rapid and safe evaluation of patients presenting with suspected acute cardiac syndrome at this time. The position statement complements, and should be read in conjunction with, the National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016: Section 2 ‘Assessment of Possible Cardiac Chest Pain’.

Original language	English
Pages (from-to)	e105-e110
Number of pages	6
Journal	International Journal of Pharmaceutics
Volume	29
Issue number	7
DOIs	https://doi.org/10.1016/j.hlc.2020.05.003
Publication status	Published - Jul 2020
Externally published	Yes

Keywords

Acute coronary syndrome
Chest pain
COVID-19

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.hlc.2020.05.003Licence: In Copyright

Cite this

Parsonage, W. A., Cullen, L., Brieger, D., Hillis, G. S., Nasis, A., Dwyer, N., Wahi, S., Lo, S., Than, M., Kerr, A., Devlin, G., & Chew, D. K. (2020). CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic. International Journal of Pharmaceutics, 29(7), e105-e110. https://doi.org/10.1016/j.hlc.2020.05.003

@article{ab3fd5c2a211427ba18b1d4e023ba4f8,

title = "CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic",

abstract = "A pandemic of Coronavirus-19 disease was declared by the World Health Organization on March 11, 2020. The pandemic is expected to place unprecedented demand on health service delivery. This position statement has been developed by the Cardiac Society of Australia and New Zealand to assist clinicians to continue to deliver rapid and safe evaluation of patients presenting with suspected acute cardiac syndrome at this time. The position statement complements, and should be read in conjunction with, the National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016: Section 2 {\textquoteleft}Assessment of Possible Cardiac Chest Pain{\textquoteright}.",

keywords = "Acute coronary syndrome, Chest pain, COVID-19",

author = "Parsonage, {William A.} and Louise Cullen and David Brieger and Hillis, {Graham S.} and Arthur Nasis and Nathan Dwyer and Sudhir Wahi and Sidney Lo and Martin Than and Andrew Kerr and Gerard Devlin and Chew, {Derek K.}",

year = "2020",

month = jul,

doi = "10.1016/j.hlc.2020.05.003",

language = "English",

volume = "29",

pages = "e105--e110",

journal = "International Journal of Pharmaceutics",

issn = "0378-5173",

publisher = "Elsevier",

number = "7",

}

Parsonage, WA, Cullen, L, Brieger, D, Hillis, GS, Nasis, A, Dwyer, N, Wahi, S, Lo, S, Than, M, Kerr, A, Devlin, G & Chew, DK 2020, 'CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic', International Journal of Pharmaceutics, vol. 29, no. 7, pp. e105-e110. https://doi.org/10.1016/j.hlc.2020.05.003

TY - JOUR

T1 - CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic

AU - Parsonage, William A.

AU - Cullen, Louise

AU - Brieger, David

AU - Hillis, Graham S.

AU - Nasis, Arthur

AU - Dwyer, Nathan

AU - Wahi, Sudhir

AU - Lo, Sidney

AU - Than, Martin

AU - Kerr, Andrew

AU - Devlin, Gerard

AU - Chew, Derek K.

PY - 2020/7

Y1 - 2020/7

N2 - A pandemic of Coronavirus-19 disease was declared by the World Health Organization on March 11, 2020. The pandemic is expected to place unprecedented demand on health service delivery. This position statement has been developed by the Cardiac Society of Australia and New Zealand to assist clinicians to continue to deliver rapid and safe evaluation of patients presenting with suspected acute cardiac syndrome at this time. The position statement complements, and should be read in conjunction with, the National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016: Section 2 ‘Assessment of Possible Cardiac Chest Pain’.

AB - A pandemic of Coronavirus-19 disease was declared by the World Health Organization on March 11, 2020. The pandemic is expected to place unprecedented demand on health service delivery. This position statement has been developed by the Cardiac Society of Australia and New Zealand to assist clinicians to continue to deliver rapid and safe evaluation of patients presenting with suspected acute cardiac syndrome at this time. The position statement complements, and should be read in conjunction with, the National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016: Section 2 ‘Assessment of Possible Cardiac Chest Pain’.

KW - Acute coronary syndrome

KW - Chest pain

KW - COVID-19

UR - http://www.scopus.com/inward/record.url?scp=85087007811&partnerID=8YFLogxK

U2 - 10.1016/j.hlc.2020.05.003

DO - 10.1016/j.hlc.2020.05.003

M3 - Letter

C2 - 32601022

AN - SCOPUS:85087007811

SN - 0378-5173

VL - 29

SP - e105-e110

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

IS - 7

ER -

CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this